Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: January 28, 2010
Reporting Period: Fourth quarter and full year ended December 31, 2009.
This filing serves as a notification that the Company issued a press release announcing its financial results for the specified period. The detailed results are contained in the press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2), which are incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 (Press Release) and Exhibit 99.2 (Supplemental Information), which are not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of results for the fourth quarter and twelve months of 2009.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the incorporated press release and supplemental exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2009 revenue, net income, and earnings per share figures.
- Examine Exhibit 99.2 for supplemental data regarding product sales, geographic performance, and R&D pipeline updates.
- Verify any guidance or outlook statements provided in the press release for the 2010 fiscal year.
- Check for any disclosures regarding patent expirations, litigation, or regulatory actions mentioned in the full press release.